Showing results (41-50 of 79) with videos related to
Sort By:
Pageof 8
Medecine Sciences : M/S|September 8, 2025
[Transitioning to adult oncology for adolescents and young adults (AYAs): The experience of an AYA unit]Séverine Chiesa, Natacha Naoun, Fanny Morin, et al.European Urology|August 5, 2026
EORTC 2238 DE-ESCALATE: Revisiting Intermittent Maximal Androgen Blockade in Metastatic Hormone-sensitive Prostate CancerGuillaume Grisay, Fabio Turco, Anna Patrikidou, et al.Targeted Oncology|May 26, 2020
Gastric Inflammatory Prognostic Index (GIPI) in Patients with Metastatic Gastro-Esophageal Junction/Gastric Cancer Treated with PD-1/PD-L1 Immune Checkpoint InhibitorsVincenzo Formica, Cristina Morelli, Anna Patrikidou, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|February 14, 2012
Bortezomib reverses the proliferative and antiapoptotic effect of neuropeptides on prostate cancer cellsKonstantinos Tsapakidis, Panagiotis J Vlachostergios, Ioannis A Voutsadakis, et al.Pathology Oncology Research : POR|July 26, 2011
p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancerPanagiotis J Vlachostergios, Foteini Karasavvidou, Anna Patrikidou, et al.Prostate Cancer|June 6, 2012
Expression of neutral endopeptidase, endothelin-1, and nuclear factor kappa B in prostate cancer: interrelations and associations with prostate-specific antigen recurrence after radical prostatectomyPanagiotis J Vlachostergios, Foteini Karasavvidou, Grigorios Kakkas, et al.Journal of Gastrointestinal Oncology|November 17, 2022
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancerCristina Morelli, Vincenzo Formica, Anna Patrikidou, et al.Cancers|August 26, 2022
The Role of CT in the Staging and Follow-Up of Testicular Tumors: Baseline, Recurrence and PitfallsThibaut Pierre, Fatine Selhane, Elise Zareski, et al.Therapeutic Advances in Medical Oncology|October 2, 2025
The future of androgen receptor targeting in prostate cancer: third-generation inhibitors and beyondAlice Bernard-Tessier, Natacha Naoun, Solenn Barraud, et al.European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 10, 2016
Outcomes and prognostic factors for squamous cell carcinoma of the oral tongue in young adults: a single-institution case-matched analysisPierre Blanchard, Farid Belkhir, Stéphane Temam, et al.Pageof 8